News Center
Welcome to the News Center, 
please read the latest news and activities of Aktin.
CPHI China 2026 Wrap-up | Thank You for the Encounters, and Looking Forward to Our Next Meeting - AKTIN
2026-06-19

On June 18, CPHI China 2026 concluded with great success at the Shanghai New International Expo Centre. While the three-day industry event has drawn to a close, the in-depth exchanges and collaborations between Aktin Chemicals,Inc. and its global partners are just embarking on a new chapter.





Three Days of Dialogue, Joint Pursuit of Growth
With over two decades of deep cultivation in the natural products sector, technological innovation remains the core strength of Aktin Chemicals,Inc. At this year's exhibition, we showcased a diverse portfolio of premium natural ingredients at Booth E5E60. Leveraging our three advanced technology platforms—Phytopower® (Development Platform of Bioactive Molecules & Ingredients from Global Medicinal Plants), Aktinsyn® (Technology Platform of Synthetic Chemistry), and Aktinbio® (Development Platform of Biotechnology)—the company comprehensively demonstrated its product layout and R&D accumulation across nutritional, personal care, and pharmaceutical ingredients. This display highlighted AKTIN's full-chain service capabilities, spanning from source R&D to industrial application.



Throughout the exhibition, our booth buzzed with activity, drawing numerous domestic and international industry peers for extensive exchanges. In addition to the high interest in its core products, AKTINPHARM® integrated CRDMO services became a major highlight. Covering natural medicines, small molecule APIs, peptides, ADC Linker-Payloads, and oligonucleotides/LNP delivery materials, this full-suite offering attracted a steady stream of R&D, supply chain, and production heads from various pharmaceutical companies. Discussions spanned drug discovery, API process development, CMC research, regulatory support, and commercial production.







Through these face-to-face, in-depth discussions, we gained invaluable market feedback, injecting fresh insights into our future product innovation and market expansion.




Gratitude for Every Encounter, Walking Forward Together


We extend our heartfelt gratitude to every client and partner who visited our booth!


While CPHI China 2026 has concluded, our collaboration and communication continue. We look forward to meeting you again!


Moving forward,  Aktin Chemicals,Inc. will remain driven by technological innovation. We will continue to deepen our expertise in nutrition & health, personal care, and pharmaceuticals, continuously enhancing the value of our products and services. Together with our global partners, we aim to co-create more development opportunities.

Cart
TotalProducts
Request Quote
  • China
  • Afghanistan
  • Albania
  • Algeria
  • Andorra
  • Angola
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Central African Republic
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Congo (Brazzaville)
  • Congo (Kinshasa)
  • Cook Islands
  • Costa Rica
  • Côte d'Ivoire
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor (Timor-Leste)
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Fiji
  • Finland
  • France
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Greece
  • Grenada
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • South Korea
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Mauritania
  • Mauritius
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Mozambique
  • Myanmar (Burma)
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sri Lanka
  • Sudan
  • South Sudan
  • Suriname
  • Sweden
  • Switzerland
  • Syria
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates (UAE)
  • United Kingdom (UK)
  • United States (US)
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Yemen
  • Zambia
  • Zimbabwe
  • Beijing-Beijing
  • Tianjin-Tianjin
  • Hebei-Shijiazhuang
  • Shanxi-Taiyuan
  • Inner Mongolia-Hohhot
  • Liaoning-Shenyang
  • Jilin-Changchun
  • Heilongjiang-Harbin
  • Shanghai-Shanghai
  • Jiangsu-Nanjing
  • Zhejiang-Hangzhou
  • Anhui-Hefei
  • Fujian-Fuzhou
  • Jiangxi-Nanchang
  • Shandong-Jinan
  • Henan-Zhengzhou
  • Hubei-Wuhan
  • Hunan-Changsha
  • Guangdong-Guangzhou
  • Guangxi-Nanning
  • Hainan-Haikou
  • Chongqing-Chongqing
  • Sichuan-Chengdu
  • Guizhou-Guiyang
  • Yunnan-Kunming
  • Tibet-Lhasa
  • Shaanxi-Xi'an
  • Gansu-Lanzhou
  • Qinghai-Xining
  • Ningxia-Yinchuan
  • Xinjiang-Urumqi
  • Hong Kong-Hong Kong
  • Macao-Macao
  • Taiwan-Taipei